Adaptive Biotechnologies CorporationADPTNASDAQ

Revenue (LTM)

$277M

+54.8% YoY

Net Income (LTM)

$-59M

+62.7% YoY

Free Cash Flow

$-49M

Revenue CAGR (5Y)

+23.0%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	154	185↑20.1%	170↓8.1%	179↑5.1%	277↑54.8%
Gross Profit	105	127↑21.3%	95↓25.6%	107↑12.8%	206↑92.4%
Operating Income	-209	-200↑4.2%	-227↓13.4%	-163↑28.4%	-57↑64.9%
Net Income	-207	-200↑3.4%	-225↓12.5%	-159↑29.2%	-59↑62.7%
EBITDA	-193	-175↑9.4%	-189↓8.0%	-129↑32.0%	-30↑76.8%
EPS Diluted	-1.46	-1.00↑31.5%	-1.56↓56.0%	-1.08↑30.8%	-0.39↑63.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	139	90↓35.3%	65↓27.7%	48↓26.3%	70↑47.1%
Total Current Assets	403	562↑39.6%	410↓27.0%	284↓30.8%	300↑5.8%
Total Assets	923	857↓7.2%	661↓22.8%	539↓18.4%	513↓4.9%
Total Current Liabilities	114	110↓3.5%	88↓19.8%	98↑11.4%	90↓8.3%
Total Liabilities	319	393↑23.0%	353↓10.1%	337↓4.5%	288↓14.6%
Total Equity	604	464↓23.2%	308↓33.6%	203↓34.3%	219↑7.9%
Total Debt	112	108↓3.3%	99↓8.5%	89↓9.5%	281↑213.9%
Net Debt	-27	18↑165.8%	34↑87.6%	41↑23.0%	210↑406.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-193	-184↑4.6%	-156↑15.0%	-95↑39.1%	-46↑51.7%
Capital Expenditure	-62	-16↑73.5%	-11↑34.6%	-4↑65.7%	-3↑19.2%
Free Cash Flow	-254	-200↑21.3%	-167↑16.6%	-99↑40.8%	-49↑50.5%
Stock-Based Comp	0	0	0	54	51↓4.0%
Net Change in Cash	16	-49↓413.7%	-25↑49.1%	-17↑31.2%	22↑230.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance